MENUCLOSE

 

News

ArcheMedX Achieves Data Milestone Modeling Over 25 Million Learning Behaviors

ArcheMedX, a behavioral science-based learning company providing a smarter way to predict and improve clinical team performance, recently passed a significant data milestone. PRWeb - Charlottesville, VA March 24, 2022 Today, the Company announced its clinician learning and predictive analytics platform, Ready, has now surpassed more than 25 million essential learning behaviors
Continue Reading

AMA Recognizes ArcheMedX’s COVID-19 Report on Virtual Tech in Clinical Trials for Excellence

Today, ArcheMedX announced that its 2020 industry report, “COVID-19's Impact on Virtual Tech in Clinical Trials, was honored with a prestigious American Marketing Association (AMA) award. Every year, the AMA honors hundreds of stand-out marketers through awards programs presented by the AMA Foundation, local professional chapters, and academic special interest groups.
Continue Reading

ValenzaBio Selects Ready by ArcheMedX to Expedite Biomarker Study

CHARLOTTESVILLE, VA Apr. 21, 2021 -- ArcheMedX announced today that ValenzaBio, a biotech focused on developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, has selected Ready, the industry’s leading clinical trial learning and predictive analytics platform, to optimize performance on its upcoming Phase II study. ValenzaBio is deploying Ready to
Continue Reading